3L17

Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer


Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.


Version NumberVersion DateVersion Type/Reason Version ChangeRevised CIF Category
1.02010-02-16Initial release
1.12011-07-13Advisory, Version format compliance
1.22017-11-01Refinement descriptionsoftware
1.32023-09-06Data collection, Database references, Derived calculations, Refinement descriptionchem_comp_atom, chem_comp_bond, database_2, pdbx_initial_refinement_model, struct_ref_seq_dif, struct_site Download